SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-007437
Filing Date
2019-04-30
Accepted
2019-04-30 16:17:17
Documents
99
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f20f2018_enlivextherap.htm 20-F 2399955
2 ENLIVEX THERAPEUTICS LTD. 2014 GLOBAL SHARE INCENTIVE PLAN f20f2018ex4-2_enlivextherap.htm EX-4.2 97868
3 FORM OF INDEMNIFICATION AGREEMENT f20f2018ex4-5_enlivextherap.htm EX-4.5 63843
4 AGREEMENT BETWEEN THE COMPANY AND A.S. NOVIK, DATED AS OF SEPTEMBER 7, 2018 f20f2018ex4-6_enlivextherap.htm EX-4.6 34464
5 EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND SHMUEL HESS, DATED AS OF NOVEMBER 1 f20f2018ex4-7_enlivextherap.htm EX-4.7 185497
6 EMPLOYMENT AGREEMENT BETWEEN THE COMPANY AND SHACHAR SHLOSBERGER, DATED AS OF MA f20f2018ex4-8_enlivextherap.htm EX-4.8 115604
7 CONSULTING AGREEMENT BETWEEN THE COMPANY, HADASIT MEDICAL RESEARCH SERVICES AND f20f2018ex4-9_enlivextherap.htm EX-4.9 77033
8 LICENSE AGREEMENT BETWEEN THE COMPANY AND TOLAREN LTD., DATED AS OF APRIL 30, 20 f20f2018ex4-10_enlivextherap.htm EX-4.10 57242
9 LICENSE AGREEMENT BETWEEN THE COMPANY, HADASIT MEDICAL RESEARCH SERVICES AND DEV f20f2018ex4-11_enlivextherap.htm EX-4.11 54934
10 LIST OF SUBSIDIARIES OF ENLIVEX THERAPEUTICS LTD. f20f2018ex8-1_enlivextherap.htm EX-8.1 2533
11 CERTIFICATION f20f2018ex12-1_enlivextherap.htm EX-12.1 6965
12 CERTIFICATION f20f2018ex12-2_enlivextherap.htm EX-12.2 6948
13 CERTIFICATION f20f2018ex13-1_enlivextherap.htm EX-13.1 3269
14 CERTIFICATION f20f2018ex13-2_enlivextherap.htm EX-13.2 3188
15 CONSENT OF CONSENT OF YAREL + PARTNERS f20f2018ex15-1_enlivextherap.htm EX-15.1 2505
16 LETTER TO THE SEC FROM KOST, FORER, GABBAY & KASIERER, A MEMBER OF EY GLOBAL f20f2018ex16-1_enlivextherap.htm EX-16.1 1786
17 GRAPHIC logo.jpg GRAPHIC 21758
18 GRAPHIC img_001.jpg GRAPHIC 26566
19 GRAPHIC img_002.jpg GRAPHIC 29042
20 GRAPHIC img_003.jpg GRAPHIC 29402
21 GRAPHIC img_004.jpg GRAPHIC 21164
22 GRAPHIC img_005.jpg GRAPHIC 29119
23 GRAPHIC image_001.jpg GRAPHIC 7988
  Complete submission text file 0001213900-19-007437.txt   8032341

Data Files

Seq Description Document Type Size
24 XBRL INSTANCE FILE enlv-20181231.xml EX-101.INS 1380665
25 XBRL SCHEMA FILE enlv-20181231.xsd EX-101.SCH 62198
26 XBRL CALCULATION FILE enlv-20181231_cal.xml EX-101.CAL 60766
27 XBRL DEFINITION FILE enlv-20181231_def.xml EX-101.DEF 193150
28 XBRL LABEL FILE enlv-20181231_lab.xml EX-101.LAB 372079
29 XBRL PRESENTATION FILE enlv-20181231_pre.xml EX-101.PRE 299446
Mailing Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042
Business Address 37 DEREH MENACHEM BEGIN ST. 15TH FLOOR TEL AVIV L3 6522042 972 (0) 3 7326616
Enlivex Therapeutics Ltd. (Filer) CIK: 0001596812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36578 | Film No.: 19781970
SIC: 2834 Pharmaceutical Preparations